Sign in

You're signed outSign in or to get full access.

About Margaret L. Wolff

Independent Board Member (since 2016) across 217 Nuveen funds; year of birth 1955. Former Skadden, Arps M&A attorney who advised boards and senior management on governance, fiduciary and strategic matters; B.A. from Mount Holyoke College and J.D. from Case Western Reserve University School of Law. Current trustee roles include New York-Presbyterian Hospital (since 2005) and The John A. Hartford Foundation (trustee since 2004; Chair 2015–2022). Classified as an Independent Board Member under the 1940 Act and exchange standards.

Past Roles

OrganizationRoleTenureCommittees/Impact
Skadden, Arps, Slate, Meagher & Flom LLPOf Counsel, M&A Group2005–2014Advised boards/senior management on U.S./international corporate, securities, governance and fiduciary issues
Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company (Travelers Canada)Director2013–2017Subsidiaries of The Travelers Companies, Inc.
Mount Holyoke CollegeTrustee; Vice ChairTrustee 2005–2015; Vice Chair 2011–2015Board leadership experience

External Roles

OrganizationRoleTenureFocus
New York-Presbyterian HospitalTrusteeSince 2005Healthcare governance
The John A. Hartford FoundationTrustee; ChairTrustee since 2004; Chair 2015–2022Philanthropy focused on care of older adults

Board Governance

  • Independence: All nominees and current members (including Wolff) are “not interested persons” and thus Independent Board Members under the 1940 Act and exchange standards.
  • Committee leadership: Chair, Compliance, Risk Management & Regulatory Oversight Committee (members: Forrester, Kenny, Medero, Moschner, Toth).
  • Committee memberships:
    • Audit Committee (Nelson, Chair; members include Wolff).
    • Nominating & Governance Committee (Young, Chair; members include Wolff).
    • Investment Committee (Boateng & Lancellotta, Co-Chairs; members include Wolff).
    • Closed-End Fund Committee (Moschner, Chair; members include Wolff).
  • Attendance: Each Board Member attended at least 75% of Board and applicable committee meetings in the last fiscal year.
  • Elections/classification: For several funds, Wolff serves as a Class I Board Member (last elected August 5, 2022 for applicable funds); for Municipal Income, she serves as Class III. For certain funds with Preferred Shares, Wolff is a nominee for election by Preferred holders.
  • Scope: Oversees 217 portfolios in the Fund Complex.

Fixed Compensation

ComponentAmountEffective/PeriodNotes
Annual retainer (Independent Board Members)$350,000Effective Jan 1, 2025Base director retainer
Committee membership retainers$35,000 (Audit); $35,000 (Compliance); $30,000 (Investment); $25,000 (Dividend); $25,000 (Nominating & Governance); $25,000 (Closed-End)Effective Jan 1, 2025Per committee membership
Chair premiums$150,000 (Board Chair); $35,000 (Audit Chair); $35,000 (Compliance Chair); $30,000 (Investment Chair/Co-Chair); $25,000 (Dividend Chair; Nominating & Governance Chair; Closed-End Chair)Effective Jan 1, 2025Additional to membership
Ad hoc meeting fees$1,000 or $2,500OngoingBased on length/immediacy
Special assignment committee feesChair/Co-Chair: quarterly from $1,250; Members: quarterly from $5,000OngoingAs designated
Prior structure (through Dec 31, 2024)$350,000 annual retainer; committee retainers at $30,000 (Audit/Compliance), $20,000 (Investment), $20,000 (Dividend/NomGov/Closed-End)Through Dec 31, 2024Transitioned from pre-2024 per-meeting model
2023 model (pre-Jan 1, 2024)$210,000 annual retainer + per-meeting fees (e.g., Board $7,250; Audit/Closed-End/Investment $2,500; Compliance $5,000; Dividend $1,250; others $500) + Chair retainers ($140,000 Board; $20,000 committee chairs)Calendar year 2023Per-meeting structure
Aggregate compensation (Wolff)$535,644Last fiscal yearTotal from Nuveen Funds paid to Board Members/Nominees
Deferred Compensation PlanAvailable; deferrals credited to a book account tracking eligible Nuveen funds; distributions lump sum or 2–20 yearsOngoingNo fund pensions/retirement plans

Performance Compensation

ElementDisclosureNotes
Performance-based awards (options/RSUs/PSUs; metric-linked)None disclosed for directorsCompensation comprises retainers/fees; no performance metrics for director pay were specified

Other Directorships & Interlocks

Company/OrganizationTypeRoleTenureInterlock/Notes
Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company (Travelers Canada)Subsidiaries of public companyDirector2013–2017No current public company board roles disclosed
New York-Presbyterian HospitalNon-profitTrusteeSince 2005
The John A. Hartford FoundationNon-profitTrustee; ChairTrustee since 2004; Chair 2015–2022
Mount Holyoke CollegeAcademicTrustee; Vice ChairTrustee 2005–2015; Vice Chair 2011–2015

Expertise & Qualifications

  • 30+ years as a corporate/M&A attorney at Skadden focused on governance, fiduciary duties, and complex strategic transactions; brings deep boardroom advisory experience.
  • Oversees 217 portfolios; extensive closed-end fund governance exposure.
  • Education: B.A. (Mount Holyoke); J.D. (Case Western Reserve University School of Law).

Equity Ownership

MeasureValueDate/Scope
Dollar range in Nuveen New York AMT-Free fund (NRK family “New York AMT-Free”)$0As of May 31, 2025
Dollar range in all registered investment companies overseen (Fund Complex)Over $100,000As of May 31, 2025
Beneficial shares in NRK family fund (“New York AMT-Free”)0As of May 31, 2025
Ownership as % of outstanding shares (each Fund)<1% (individual and group)As of June 20, 2025
Ownership guidelineBoard principle: invest at least the equivalent of one year of compensation in funds in the Fund ComplexPolicy statement; individual compliance level not quantified in proxy
Deferred compensation amounts attributed to Wolff (examples)AMT-Free Quality (FY): $7,091; Quality Income (FY): $5,666; Municipal Income (FY): $117; New York AMT-Free (FY): $3,185; New York AMT-Free (Stub): $775As disclosed for Participating Funds; totals are fund-specific, not aggregated

Governance Assessment

  • Strengths

    • Independent director with significant governance/legal expertise; chairs the Compliance, Risk Management & Regulatory Oversight Committee and serves on Audit, Nominating & Governance, Investment, and Closed-End Fund committees—signals active oversight across risk, valuation and governance processes.
    • Attendance threshold met (≥75%) amid a heavy meeting load per Appendix C; supports engagement.
    • No Section 16(a) delinquency; Board transitions auditors from KPMG to PwC with standard independence representations—supports controls focus.
  • Potential concerns / monitoring items

    • RED FLAG: $0 disclosed holding in the NRK family fund (“New York AMT-Free”), despite a board principle encouraging at least one-year compensation invested across the Fund Complex; aggregate range “Over $100,000” is insufficient to confirm guideline compliance at the individual level. Consider shareholder alignment optics at the fund-specific level.
    • No related-party transactions disclosed for Wolff; however, the proxy highlights another director’s investments in entities under common control with the adviser—maintain vigilance for any future interlocks.
    • Compensation structure increased fixed retainers and committee retainers effective Jan 1, 2025 from prior levels; while consistent with workload, rising guaranteed pay vs. per-meeting fees may reduce direct pay-for-workload sensitivity.